Harvard-wide Pediatric Health Services Research Fellowship Program
Professor of Pediatrics, Harvard Medical School, and Professor of Immunology and Infectious Diseases, and Epidemiology, Harvard School of Public Health.
Dr. Goldmann has provided overall vision and leadership for the Harvard Pediatric Health Services Research Training Program since its inception more than 15 years ago. He brings a unique perspective to translational research, having performed studies across the entire continuum of translational research: bench science (vaccine development), infectious disease epidemiology, clinical trials (including cluster randomized trials of QI interventions), and QI research. He is internationally known for his pioneering studies that elucidated risk factors for and evidence-based practices to prevent healthcare associated infections and antibiotic resistance. He participated in implementation and evaluation of CDC’s NNIS (now the NHSN), elucidated risk factors and outcomes of neonatal healthcare associated infections,and was on the team that developed and validated SNAP (score for neonatal acute physiology) and other risk-adjustment methods. He served on CDC’s HICPAC (which formulates guidelines based on comparative effectiveness research) and the Steering Committee of NACHRI/CDC Pediatric Prevention Network. Dr. Goldmann was PI of the antibiotic resistance research group of the NIAID-funded Bacteriology and Mycology Group, which performed the first NIH-sponsored trials of infection control interventions, including a cluster randomized trial of active surveillance to reduce transmission of MRSA and VRE. He implemented and evaluated infection-related QI strategies in a number of developing countries (funded by USAID).
Dr. Goldmann was Medical Director of QI at Children’s Hospital Boston for more than 10 years, where he led development and evaluation of clinical practice guidelines based on comprehensive evidence review and, with Dr. Charles Homer, developed and validated surveys to measure perceptions of inpatient and ambulatory care. He has a strong track record in patient safety, including a lead role in the Vermont Oxford Network’s (VON) NIC/Q collaborative. He was a Co-Investigator on Dr. Bates’ AHRQ P01 Center for Excellence for Patient Safety and Practice and VON’s neonatal patient safety DCERPS.
Dr. Goldmann now is Sr. Vice President at the Institute for Healthcare Improvement (IHI), while retaining his academic responsibilities at Harvard. He has built an innovative and productive research team, including rapid-cycle R&D and innovation, health and health care measurement, pilot and feasibility testing of novel improvement strategies, and multi-method evaluation of demonstration projects. He is PI on IHI’s AHRQ ACTION II Award, a CDC antibiotic stewardship grant, an ASPE-funded cluster randomized trial of a multi-modal state-based system to spread CER best practices, and a Macy interdisciplinary education grant. He has been the IHI senior sponsor for an initiative to improve ambulatory prevention and care in the Indian Health Service, an ASPE-funded project to design novel methods to engage providers and patients to improve colon cancer screening, a Commonwealth Fund-supported project to reduce all-cause readmissions in three states, and a project to improve HCAHPS in the 150-plus hospitals of a major health care company. He also is a co-investigator on a CDC-funded grant to the Harvard School of Public Health to improve emergency preparedness. Dr. Goldmann directs IHI’s fellowship program, which has more than 40 national and international alumni. He is IHI’s liaison for a number of strategic relationships, including ACGME, AAMC, ABIM, ABMS, AHRQ, CDC, and NQF.
Selected Peer-Reviewed Publications (since 1998, from 218 total peer-reviewed publications)
- Homer CJ, Marion B, Cleary PT, Alpert HR, Smith B, Crowley Ganser CM, Brustowicz RM, Goldmann DA. Quality of care at a children’s hospital: the parent’s perspective. Arch Pediatr Adolesc Med. 1999;153:1123-9. (PMID10555712)
- Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, Goldmann DA. Medication errors and adverse events in pediatric inpatients. JAMA. 2001;285:2114-20. (PMID11311101)
- Weinberg M, Fuentes JM, Ruiz AI, Lozano FW, Angel E, Gaitan H, Goethe B, Parra S, Hellerstein S, Ross-Degnan D, Goldmann DA, Huskins WC. Reducing infections among women undergoing Cesarean section in Colombia using continuous quality improvement methods. Arch Int Med 2001;161:2357-64. (PMID11606152)
- Landrigan C, Srivastava R, Muret-Wagstaff S, Soumerai SB, Ross-Degnan D, Graef JW, Homer CJ, Goldmann DA. Impact of an HMO hospitalist system in academic pediatrics: length of stay, costs, continuity, and parental ratings of care. Pediatrics 2002 ;110:720-8. (PMID12359785)
- Suresh G, Horbar J, Plsek P, Gray J, Edwards WH, Shiono P, Ursprung R, Nickerson J, Lucey JF, Goldmann DA. Voluntary anonymous reporting of medical errors for neonatal intensive care. Pediatrics 2004; 113:1609-18. (PMID15173481)
- Ursprung R, Gray JE, Edwards WH, Horbar JD, Nickerson J, Plsek P, Shiono PH, Suresh GK, Goldmann DA. Real time patient safety audits: improving safety every day. Qual Saf Health Care 2005;14:284-89. (PMID16076794)
- Sandora TJ, Taveras EM, Shih MC, Resnick EA, Lee GM, Ross-Degnan D, Goldmann DA. A randomized controlled trial of a multifaceted hand hygiene intervention including alcohol-based hand sanitizer and hand hygiene education to reduce illness transmission in the home. Pediatrics. 2005;116:587-94. (PMID16140697)
- Kalish LA, Waltz DA, Dovey M, Potter-Bynoe G, McAdam AJ, LiPuma JJ, Gerard C, Goldmann DA. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med. 2006; 173: 421-25.
- Predictors of clinical outcomes and hospital resource use of children after tracheotomy. Pediatrics 2009; 124: 563-72
- Power M, Wigglesworth N, Donaldson E, Chadwick P, Gillibrand S, Goldmann D. Reducing Clostridum difficile infection in acute care by using an improvement collaborative. BMJ 2010; 341: c3359
- Landrigan CP, Parry GJ, Bones CB, Hackbarth AD, Goldmann DA, Sharke PJ. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med 2010; 363: 2124-34
- Huskins C, Huckabee C, O’Grady N, Murray P, Kopestskie H, Zimmer L, Walker M, Sinkowitz-Cochran R, Jernigan J, Samore M, Wallace D, Goldmann D. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011; 364: 1407-18
- Sullivan P, Goldmann D. The promise of comparative effectiveness research. JAMA 2011;305:400-1
- Chin MH, Goldmann D. Meaningful disparities reduction through research and translation programs. JAMA 2011;305:404-5
- Pogorzelska M, Stone PW, Furuya EY, Perencevich EN, Larson EL, Goldmann D, Dick A. Impact of the ventilator bundle of on ventilator-associated pneumonia in intensive care unit. Int J Qual Healthcare 2011; 538-44.